BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar J, Fraser FW, Riley C, Ahmed N, McCulloch DR, Ward AC. Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer. Br J Cancer 2014;110:133-45. [PMID: 24220695 DOI: 10.1038/bjc.2013.673] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Wu CJ, Sundararajan V, Sheu BC, Huang RY, Wei LH. Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity. Cancers (Basel) 2019;12:E24. [PMID: 31861720 DOI: 10.3390/cancers12010024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
2 Pan B, Shen J, Cao J, Zhou Y, Shang L, Jin S, Cao S, Che D, Liu F, Yu Y. Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer. Sci Rep 2015;5:16053. [PMID: 26524953 DOI: 10.1038/srep16053] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 10.4] [Reference Citation Analysis]
3 Kumar J, Fang H, McCulloch DR, Crowley T, Ward AC. Leptin receptor signaling via Janus kinase 2/Signal transducer and activator of transcription 3 impacts on ovarian cancer cell phenotypes. Oncotarget 2017;8:93530-40. [PMID: 29212170 DOI: 10.18632/oncotarget.19873] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
4 López-Salazar J, Ramírez-Tirado LA, Gómez-Contreras N, Pacheco-Bravo I, Cortés E, Gallardo D, Arrieta O, Cesarman-Maus G. Cancer-associated prothrombotic pathways: leucocytosis, but not thrombocytosis, correlates with venous thromboembolism in women with ovarian cancer. Intern Med J 2020;50:366-70. [PMID: 32141210 DOI: 10.1111/imj.14762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Cai L, Jeon Y, Yoon JD, Hwang SU, Kim E, Park KM, Kim KJ, Jin MH, Lee E, Kim H, Jeung EB, Hyun SH. The effects of human recombinant granulocyte-colony stimulating factor treatment during in vitro maturation of porcine oocyte on subsequent embryonic development.Theriogenology. 2015;84:1075-1087. [PMID: 26194698 DOI: 10.1016/j.theriogenology.2015.06.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
6 Kumar J, Ward AC. Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications. Biochim Biophys Acta 2014;1845:117-25. [PMID: 24388871 DOI: 10.1016/j.bbcan.2013.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
7 Mouchemore KA, Anderson RL, Hamilton JA. Neutrophils, G-CSF and their contribution to breast cancer metastasis. FEBS J 2018;285:665-79. [PMID: 28834401 DOI: 10.1111/febs.14206] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 11.4] [Reference Citation Analysis]
8 Zhao YY, Yu L, Liu BL, He XJ, Zhang BY. Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines. Mol Med Rep 2015;12:7335-43. [PMID: 26459009 DOI: 10.3892/mmr.2015.4367] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
9 Velloso FJ, Bianco AF, Farias JO, Torres NE, Ferruzo PY, Anschau V, Jesus-Ferreira HC, Chang TH, Sogayar MC, Zerbini LF, Correa RG. The crossroads of breast cancer progression: insights into the modulation of major signaling pathways. Onco Targets Ther 2017;10:5491-524. [PMID: 29200866 DOI: 10.2147/OTT.S142154] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
10 Cai L, Jeong YW, Jin YX, Lee JY, Jeong YI, Hwang KC, Hyun SH, Hwang WS. Effects of human recombinant granulocyte-colony stimulating factor treatment during in vitro culture on porcine pre-implantation embryos. PLoS One 2020;15:e0230247. [PMID: 32182268 DOI: 10.1371/journal.pone.0230247] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Thomas SJ, Snowden JA, Zeidler MP, Danson SJ. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer. 2015;113:365-371. [PMID: 26151455 DOI: 10.1038/bjc.2015.233] [Cited by in Crossref: 265] [Cited by in F6Publishing: 252] [Article Influence: 37.9] [Reference Citation Analysis]
12 Kumar J, Kaur G, Ren R, Lu Y, Lin K, Li J, Huang Y, Patel A, Barton MC, Macfarlan T, Zhang X, Cheng X. KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells. NAR Cancer 2020;2:zcaa007. [PMID: 32743551 DOI: 10.1093/narcan/zcaa007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhang L, Tao L, Guo L, Zhan J, Yuan C, Ma Z, Jiang B, Xiu D. G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma. Cancer Manag Res 2018;10:2767-75. [PMID: 30147373 DOI: 10.2147/CMAR.S165226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Zhao CL, Zhang GP, Xiao ZZ, Ma ZK, Lei CP, Song SY, Feng YY, Zhao YC, Feng XS. Recombinant Human Granulocyte Colony-Stimulating Factor Promotes Preinvasive and Invasive Estrogen Receptor-Positive Tumor Development in MMTV-erbB2 Mice. J Breast Cancer 2015;18:126-33. [PMID: 26155288 DOI: 10.4048/jbc.2015.18.2.126] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
15 Fan Z, Li Y, Zhao Q, Fan L, Tan B, Zuo J, Hua K, Ji Q. Highly Expressed Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) in Human Gastric Cancer Leads to Poor Survival. Med Sci Monit 2018;24:1701-11. [PMID: 29567938 DOI: 10.12659/msm.909128] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
16 Maeda M, Fukuda T, Miyake M, Takahashi H, Ikegami M. Extracranial metastatic solitary fibrous tumor/hemangiopericytoma expressing G-CSF and its receptor. Neuropathology 2021;41:288-92. [PMID: 34137078 DOI: 10.1111/neup.12734] [Reference Citation Analysis]
17 Fukui Y, Kawashima M, Kawaguchi K, Takeuchi M, Hirata M, Kataoka TR, Sakurai T, Kataoka M, Kanao S, Nakamoto Y, Hirata K, Yoshimura M, Yoshikawa K, Ishiguro H, Toi M. Granulocyte-colony-stimulating factor-producing metaplastic carcinoma of the breast with significant elevation of serum interleukin-17 and vascular endothelial growth factor levels. Int Cancer Conf J 2018;7:107-13. [PMID: 31149526 DOI: 10.1007/s13691-018-0330-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
18 Kobayashi S, Nagata Y, Tokai H, Ito M, Fujioka H. Multidisciplinary therapy for granulocyte-colony-stimulating factor producing carcinosarcoma of the esophagus: report of a case. Clin Case Rep 2015;3:681-5. [PMID: 26331012 DOI: 10.1002/ccr3.295] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
19 Abubaker K, Luwor RB, Escalona R, McNally O, Quinn MA, Thompson EW, Findlay JK, Ahmed N. Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden. Front Oncol 2014;4:75. [PMID: 24782986 DOI: 10.3389/fonc.2014.00075] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
20 Zage PE, Whittle SB, Shohet JM. CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family. J Cell Biochem. 2017;118:221-231. [PMID: 27428599 DOI: 10.1002/jcb.25656] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
21 Kalamegam G, Sait KHW, Anfinan N, Kadam R, Ahmed F, Rasool M, Naseer MI, Pushparaj PN, Al-Qahtani M. Cytokines secreted by human Wharton's jelly stem cells inhibit the proliferation of ovarian cancer (OVCAR3) cells in vitro. Oncol Lett 2019;17:4521-31. [PMID: 30944641 DOI: 10.3892/ol.2019.10094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
22 Pahnke S, Nygell UA, Johansson JE, Kisch A, Ljungman P, Sandstedt A, Hägglund H, Larfors G. Cancer incidence in healthy Swedish peripheral blood stem cell donors. Bone Marrow Transplant 2022. [PMID: 35256742 DOI: 10.1038/s41409-022-01617-6] [Reference Citation Analysis]
23 Yamaguchi S, Kanetaka K, Kobayashi S, Nagata Y, Kinosita N, Fukuoka J, Murakami S, Fujita F, Takatsuki M, Eguchi S. Severe neutrophilic leukocytosis as a progression marker in granulocyte colony-stimulating factor-producing squamous cell carcinoma of the esophagus. Clin Case Rep 2017;5:688-93. [PMID: 28469877 DOI: 10.1002/ccr3.908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
24 Binder MJ, McCoombe S, Williams ED, McCulloch DR, Ward AC. ADAMTS-15 Has a Tumor Suppressor Role in Prostate Cancer. Biomolecules 2020;10:E682. [PMID: 32354091 DOI: 10.3390/biom10050682] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
25 Tzeng HT, Chyuan IT, Lai JH. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential. Biochem Pharmacol 2021;193:114760. [PMID: 34492272 DOI: 10.1016/j.bcp.2021.114760] [Reference Citation Analysis]
26 Yeo B, Redfern AD, Mouchemore KA, Hamilton JA, Anderson RL. The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression. Clin Exp Metastasis 2018;35:255-67. [PMID: 29968171 DOI: 10.1007/s10585-018-9917-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
27 Liu L, Liu Y, Yan X, Zhou C, Xiong X. The role of granulocyte colony‑stimulating factor in breast cancer development: A review. Mol Med Rep 2020;21:2019-29. [PMID: 32186767 DOI: 10.3892/mmr.2020.11017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
28 Chafe SC, Riaz N, Burugu S, Gao D, Leung SCY, Lee AF, Lee CH, Dedhar S, Nielsen TO. Granulocyte Colony Stimulating Factor Expression in Breast Cancer and Its Association with Carbonic Anhydrase IX and Immune Checkpoints. Cancers (Basel) 2021;13:1022. [PMID: 33804486 DOI: 10.3390/cancers13051022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Wright CR, Brown EL, Della-Gatta PA, Ward AC, Lynch GS, Russell AP. G-CSF does not influence C2C12 myogenesis despite receptor expression in healthy and dystrophic skeletal muscle. Front Physiol 2014;5:170. [PMID: 24822049 DOI: 10.3389/fphys.2014.00170] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
30 Wang L, Ye X, Liu Y, Wei W, Wang Z. Aberrant regulation of FBW7 in cancer. Oncotarget 2014;5:2000-15. [PMID: 24899581 DOI: 10.18632/oncotarget.1859] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]